Apremilast for the Treatment of Acute Pityriasis Lichenoides et Varioliformis Acuta: A Report of Four Cases
Indian Journal of Dermatology · 2026-11 · 71 (6) · 502-502
DOI: 10.4103/ijd.ijd_176_25 ↗Kurz gefasst
Fallbericht in der Zeitschrift Indian Journal of Dermatology, online erschienen am 30.10.2026. Verfasst von Wei Mei und 3 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Dermatology, Hangzhou Third People's Hospital, Xihu Avenue, Hangzhou, China. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Acute pityriasis lichenoides et varioliformis acuta (PLEVA), also known as Mucha-Habermann disease, is a self-limiting inflammatory dermatosis characterised by an abrupt onset of polymorphic lesions, including scaly erythematous papules, vesicles, haemorrhagic necrosis and ulceration, often leaving varioliform scars. This case series reports four male patients with PLEVA who achieved significant improvement after oral apremilast therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- From the Department of Dermatology, Hangzhou Third People's Hospital, Xihu Avenue, Hangzhou, China.
Zitieren
APA
Mei, W., Xu, T., Cao, Y., & Li, L. (2026). Apremilast for the Treatment of Acute Pityriasis Lichenoides et Varioliformis Acuta: A Report of Four Cases. Indian Journal of Dermatology, 71(6), 502-502. https://doi.org/10.4103/ijd.ijd_176_25
Vancouver
Mei W, Xu T, Cao Y, Li L. Apremilast for the Treatment of Acute Pityriasis Lichenoides et Varioliformis Acuta: A Report of Four Cases. Indian Journal of Dermatology. 2026;71(6):502-502. doi:10.4103/ijd.ijd_176_25
BibTeX
@article{Mei2026,
author = {Mei, Wei and Xu, Tianhong and Cao, Yongping and Li, Lili},
title = {Apremilast for the Treatment of Acute Pityriasis Lichenoides et Varioliformis Acuta: A Report of Four Cases},
journal = {Indian Journal of Dermatology},
year = {2026},
volume = {71},
number = {6},
pages = {502--502},
doi = {10.4103/ijd.ijd_176_25}
}
EUVIMED